Bailard’s Agilon Health AGL Stock Holding History

Bailard’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,686	Closed	-$29K	–	741
2025 Q4	$29K	Hold	1,686	–	–	﹤0.01%	743
2025 Q3	$43.4K	Hold	1,686	–	–	﹤0.01%	776
2025 Q2	$97K	Sell	1,686 -15	-0.9%	-$1.2K	﹤0.01%	740
2025 Q1	$184K	Buy	1,701 +15	+0.9%	+$1.3K	﹤0.01%	702
2024 Q4	$80.1K	Sell	1,686 -8	-0.5%	-$484	﹤0.01%	722
2024 Q3	$166K	Sell	1,694 -56	-3%	-$7.23K	﹤0.01%	718
2024 Q2	$286K	Hold	1,750	–	–	0.01%	567
2024 Q1	$267K	Hold	1,750	–	–	0.01%	590
2023 Q4	$549K	Hold	1,750	–	–	0.02%	442
2023 Q3	$777K	Buy	1,750 +32	+2%	+$14.5K	0.03%	311
2023 Q2	$745K	Buy	1,718 +32	+2%	+$18K	0.03%	306
2023 Q1	$1M	Hold	1,686	–	–	0.04%	270
2022 Q4	$680K	Buy	+1,686	New	+$791K	0.03%	328

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NPCM

North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Bailard's AGL Position: Q1 2026 in Review

Bailard sold out of Agilon Health (AGL) in Q1 2026, closing a stake of 1,686 shares — an estimated $29K sold.

Bailard first reported a position in AGL in Q4 2022 and held it in 13 quarters. The position peaked at $1M in Q1 2023. 97 funds tracked by Wall St. Rank hold AGL as of Q1 2026.

Bailard reported no remaining Agilon Health position as of Q1 2026 after selling out during the quarter.
Bailard sold 1,686 Agilon Health shares in Q1 2026, an estimated $29K.
Bailard first reported a position in Agilon Health in Q4 2022 and held it in 13 quarters.
Bailard's Agilon Health position peaked at $1M in Q1 2023.
97 funds tracked by Wall St. Rank held Agilon Health as of Q1 2026.

Based on Bailard's 13F filing for Q1 2026, filed 11 May 2026.